Literature DB >> 17244655

Towards a rational approach to combination therapy for neovascular age-related macular degeneration.

Jorge G Arroyo.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17244655      PMCID： PMC1857607          DOI： 10.1136/bjo.2006.106534

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  11 in total

1.  Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

Authors:  Olcay Tatar; Kei Shinoda; Annemarie Adam; Tillmann Eckert; Claus Eckardt; Klaus Lucke; Christoph Deuter; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.

Authors:  Olcay Tatar; Annemarie Adam; Kei Shinoda; Peter Stalmans; Claus Eckardt; Matthias Lüke; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

Authors:  J W Miller; A P Adamis; L P Aiello
Journal:  Diabetes Metab Rev       Date:  1997-03

5.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

6.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

7.  Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.

Authors:  Michael J Tolentino; D Scott McLeod; Makoto Taomoto; Tsuyoshi Otsuji; Anthony P Adamis; Gerard A Lutty
Journal:  Am J Ophthalmol       Date:  2002-03       Impact factor: 5.258

8.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy.

Authors:  Deborah C Yeh; Deisy V Bula; Joan W Miller; Evangelos S Gragoudas; Jorge G Arroyo
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  1 in total

Review 1.  Anti-VEGF Therapy and the Retina: An Update.

Authors:  Vikas Tah; Harry O Orlans; Jonathan Hyer; Edward Casswell; Nizar Din; Vishnu Sri Shanmuganathan; Louise Ramskold; Saruban Pasu
Journal:  J Ophthalmol       Date:  2015-08-31       Impact factor: 1.909
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.